Patience here will pay out in truckloads. I am very confident in that. I wish I could see into the future and know which route will be taken, but I am not a psychic. The next step as you say, wait for 3 phase 2 trials to conclude and for the data.
We've had plenty of sound bites from IPIX that partnership is their priority, that BP knows the value of their pipeline and that BP knows IPIX knows the true value, and we do have CDAs in place with several BPs and that IPIX is the farthest they have ever been in our history in regards to BP and negotiations/talks. All of the above is documented by IPIX.
Taking these promising drugs thru preclinical to now (for some) thru phase 2b is a tip of the cap for me. Not many biotechs can get to this point with one drug and one indication. We have 3 and 1 of those drugs has 3 indications moving thru phase 2 currently.
No one can take that away from us Sox. I will buy 5000 more shares today and again lock it up. That 5000 will go to my niece and most likely pay for her college in 20 years.